Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Opioid Agonist Treatment”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Not applicableEnded earlyNCT05899101
What this trial is testing

The Impact of Opioid and Cannabis Exposure on Fetal Growth

Who this might be right for
Pregnancy RelatedSubstance UseFetal Growth Retardation+1 more
Dr. Laura Gaudet 20
Post-approval studies (Phase 4)Study completedNCT05905367
What this trial is testing

Symptom-inhibited Fentanyl Induction

Who this might be right for
Opioid Use Disorder
Pouya Azar 48
Not applicableStudy completedNCT04049799
What this trial is testing

Maternal Opioid Treatment: Human Experimental Research - Data Yield Appropriate Decisions

Who this might be right for
Opioid-use DisorderOpioid WithdrawalNeonatal Abstinence Syndrome+1 more
University of Vermont 88
Large-scale testing (Phase 3)WithdrawnNCT04523792
What this trial is testing

Virginia Opioid Treatment-Emergency Department

Who this might be right for
Opioid Use Disorder
Virginia Commonwealth University
Testing effectiveness (Phase 2)Study completedNCT00877799
What this trial is testing

Study to Evaluate Analgesic Effect of Intravenous Administration of Kappa Agonist CR845 After Hysterectomy Surgery

Who this might be right for
Acute Pain
Cara Therapeutics, Inc. 114
Testing effectiveness (Phase 2)Study completedNCT04109118
What this trial is testing

Benzodiazepine Discontinuation in Opioid Agonist Therapy

Who this might be right for
Substance Use Disorders
Boston Medical Center 4
Not applicableStudy completedNCT01592461
What this trial is testing

Starting Treatment With Agonist Replacement Therapies Follow-up Study

Who this might be right for
Opioid Dependence
University of California, Los Angeles 877
Not applicableLooking for participantsNCT07178990
What this trial is testing

Mobile Platform for Optimizing Wellness and Engagement in Recovery

Who this might be right for
Opioid Agonist TreatmentAlcohol Use DisorderOpioid Use Disorder
University of Michigan 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05712707
What this trial is testing

Sublingual Dexmedetomidine for Treating Opioid Withdrawal

Who this might be right for
Opioid Use DisorderOpioid Withdrawal
New York State Psychiatric Institute 160
Post-approval studies (Phase 4)Not Yet RecruitingNCT06580873
What this trial is testing

Evaluation of Switch to Dolutegravir/Lamivudine (DTG/3TC) From Current Suppressive Antiretroviral Therapy in People Living With HIV (PLWH) Receiving Opioid Agonist Therapy (OAT)

Who this might be right for
HIV-1-infectionOpioid Use Disorder
Saskatchewan Health Authority - Regina Area 40
Not applicableStudy completedNCT05229770
What this trial is testing

Effect of Fruit Smoothie Supplementation on Psychological Distress Among People Receiving Opioid Agonist Therapy

Who this might be right for
Substance-Related Disorders
Haukeland University Hospital 324
Testing effectiveness (Phase 2)Study completedNCT04199728
What this trial is testing

Use of a GLP-1R Agonist to Treat Opioid Use Disorder

Who this might be right for
Opiate Substitution TreatmentOpioid-Related Disorders
Milton S. Hershey Medical Center 27
Not applicableNot Yet RecruitingNCT06211972
What this trial is testing

The Feasibility of the OpiVenture Program for Clients Undergoing Opioid Agonist Therapy

Who this might be right for
Opioid Use DisorderPolysubstance AddictionSubstance Use
Dalhousie University 96
Testing effectiveness (Phase 2)Looking for participantsNCT04234191
What this trial is testing

Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder

Who this might be right for
Opioid Use Disorder
University of British Columbia 50
Not applicableStudy completedNCT05242848
What this trial is testing

Integrated Exercise Program in Opioid Agonist Therapy Clinics

Who this might be right for
Substance-Related Disorders
Haukeland University Hospital 309
Large-scale testing (Phase 3)Study completedNCT00000311
What this trial is testing

Combining Behavioral Treatment With Agonist Maintenance - 1

Who this might be right for
Cocaine-Related DisordersOpioid-Related DisordersSubstance-Related Disorders
Yale University 168
Testing effectiveness (Phase 2)Study completedNCT04470050
What this trial is testing

Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal

Who this might be right for
Opioid Withdrawal
BioXcel Therapeutics Inc 225
Post-approval studies (Phase 4)Not Yet RecruitingNCT07439549
What this trial is testing

Symptom-Inhibited Naloxone Induction (SINI) for Buprenorphine Initiation: A Feasibility Trial

Who this might be right for
Opioid Use Disorder
Pouya Azar 12
Testing effectiveness (Phase 2)Study completedNCT01983306
What this trial is testing

Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)

Who this might be right for
Constipation
Bausch Health Americas, Inc. 292
Testing effectiveness (Phase 2)Looking for participantsNCT05985850
What this trial is testing

Evaluating Tetrahydrocannabinol as an Adjunct to Opioid Agonist Therapy

Who this might be right for
Opioid Use DisorderMethadoneCannabis+1 more
BC Centre on Substance Use 24
Load More Results